Home › Categories › Health & Wellness› The Avodart Monograph From GSK

The Avodart Monograph From GSK.pdf

avodart.pdf

Preview of the Avodart monograph from GSK

🔗 Source: ca.gsk.com

📊 Size: 561 KB

👤 Author: lob26442

⬇️ Downloads: 84

Summary

PrAVODART® (dutasteride) is indicated for the treatment of symptomatic Benign Prostatic Hyperplasia (BPH) in men with enlarged prostates, and is also used in combination with the alpha blocker tamsulosin for moderate to severe symptomatic BPH. It reduces prostate size, improves urinary flow and symptoms of BPH, and reduces the risk of acute urinary retention and BPH-related surgery. However, it is contraindicated for use in women and children, and in patients with known hypersensitivity to dutasteride or its components. Serious warnings and precautions include increased risk of high-grade prostate cancer, breast changes, and cardiovascular effects, particularly when used in combination with an alpha-blocker.

Download File

Description

PrAVODART® (dutasteride) is indicated for the treatment of symptomatic Benign Prostatic Hyperplasia (BPH) in men with enlarged prostates, and is also used in...

Technical Information

File Format: PDF
File Size: 561 KB
Pages: 46
Language: EN
Author: lob26442
Total Downloads: 84
Last Updated: 1 week ago

Document Overview

This PDF document about the Avodart monograph from GSK provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into the Avodart monograph from GSK.